← Back to Search

Recovery Support for Bladder Cancer

N/A

Waitlist Available

Led By Michael Diefenbach, PhD

Research Sponsored by Northwell Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Did not need or completed neo-adjuvant chemotherapy

Undergoing bladder removal surgery and one of the following urinary diversions: 1) ileal conduit, 2) neobladder or 3) Indiana pouch

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will develop and evaluate a multi-stage intervention to help patients and caregivers prepare for surgery and recovery for those with bladder cancer.

Who is the study for?

This trial is for English-speaking men and women diagnosed with bladder cancer who are about to have their bladders removed and replaced with an artificial one (ileal conduit, neobladder, or Indiana pouch). They should not be in need of or already finished with neo-adjuvant chemotherapy. Caregivers must be in a stable caregiving role, not temporary.

What is being tested?

The study tests a multi-stage intervention called Cancer Resource Information Support (CRIS) versus Usual Care Enhanced. CRIS includes pre-surgery preparation by nurses, stoma care training, and access to a recovery website with resources. The control group receives Facing Forward brochures from the National Cancer Institute.

What are the potential side effects?

Since this trial focuses on educational support rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience varying levels of emotional or psychological impact due to the nature of the information and support provided.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I did not need or have completed chemotherapy before surgery.

Select...

I am having my bladder removed and will get a new way to pass urine.

Select...

I can easily communicate in English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Quality of Life Caregiver: The Caregiver Quality of Life Index-C

Urinary Bladder

Secondary study objectives

Infection rate (biological factor)

Visiting Nurse/ER visits

Other study objectives

Exploratory Cost Analysis

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Bladder cancer patients \& caregivers receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.

Group II: Usual care enhancedActive Control1 Intervention

Bladder cancer patients \& caregivers receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.

0 / 3Eligibility criteria met